Catalyst Biosciences(CBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CBIO Catalyst Biosciences

盘前交易 12-23 05:41:51 EST

7.67

+0.00

0.00%

最高7.67	最低7.67	成交量0.00
今开7.67	昨收7.67	日振幅0.00%
总市值1,942万	流通市值1,403万	总股本253.17万
成交额25.33万	换手率0.00%	流通股本182.94万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CBIO","market":"US","secType":"STK","nameCN":"Catalyst Biosciences","latestPrice":7.6695,"timestamp":1698696000000,"preClose":7.6695,"halted":8,"volume":0,"delay":0,"floatShares":1829446,"shares":2531659,"eps":-18.278206,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"12-23 05:41:51 EST","open":7.6695,"high":7.6695,"low":7.6695,"amount":253322.474807,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.278206,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"symbolChange":{"newSymbol":"GYRE","executeDate":"2023-10-31"},"adr":0,"adjPreClose":7.6695,"adrRate":0,"dividendRate":0.031293,"volumeRatio":0},"requestUrl":"/m/hq/s/CBIO/tweets","defaultTab":"tweets","newsList":[{"id":"2379512739","title":"凯赛生物：截至10月31日已回购54.9236万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2379512739","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2379512739?lang=zh_cn&edition=full","pubTime":"2023-10-31 18:12","pubTimestamp":1698747120,"startTime":"0","endTime":"0","summary":"证券日报网讯 10月31日晚间，凯赛生物发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份54.9236万股，占公司总股本58337.8039万股的比例为0.0941%。回购成交的最高价为57.37元/股，最低价为52.90元/股，支付的资金总额人民币3057.0741万元（不含印花税、交易佣金等交易费用）。（编辑 何帆）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103118311783989b56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103118311783989b56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK0208","GYRE","688065"],"gpt_icon":0},{"id":"2379198955","title":"凯赛生物：累计回购约55万股 占比0.0941%","url":"https://stock-news.laohu8.com/highlight/detail?id=2379198955","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2379198955?lang=zh_cn&edition=full","pubTime":"2023-10-31 17:37","pubTimestamp":1698745056,"startTime":"0","endTime":"0","summary":"凯赛生物（SH 688065，收盘价：53.11元）10月31日晚间发布公告称，截至2023年10月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约55万股，占公司总股本约5.83亿股的比例为0.0941%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。截至发稿，凯赛生物市值为310亿元。文章来源：每日经济新闻原标题：凯赛生物：累计回购约55万股，占比0.0941%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103117393083d61d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK0208","688065","GYRE"],"gpt_icon":0},{"id":"2379589096","title":"Catalyst Biosciences Inc盘中异动 大幅上涨7.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2379589096","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2379589096?lang=zh_cn&edition=full","pubTime":"2023-10-30 21:30","pubTimestamp":1698672625,"startTime":"0","endTime":"0","summary":"北京时间2023年10月30日21时30分，Catalyst Biosciences Inc股票出现波动，股价急速拉升7.88%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体涨幅为0.00%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。消息层面，截至21时30分，《凯赛生物2023年前三季度净利3.14亿 同比减少35.44%》资讯为影响Catalyst Biosciences Inc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310302130258475f4fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310302130258475f4fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO","GYRE"],"gpt_icon":0},{"id":"2379304977","title":"凯赛生物2023年前三季度净利3.14亿 同比减少35.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2379304977","media":"挖贝网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2379304977?lang=zh_cn&edition=full","pubTime":"2023-10-30 19:01","pubTimestamp":1698663690,"startTime":"0","endTime":"0","summary":"挖贝网2023年10月30日，凯赛生物 近日发布2023年前三季度报,报告期内，公司实现营业收入1,565,490,018.66元,同比减少14.81%；归属于上市公司股东的净利润313,885,180.71元，同比减少35.44%。报告期内研发费用126,413,295.65元，上年同期134,754,753.10元，同比减少6.19%。挖贝网资料显示，凯赛生物的主要业务为新型生物基材料的研发、生产及销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103019034483d2d8f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103019034483d2d8f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","GYRE","BK4139","CBIO"],"gpt_icon":0},{"id":"2379307906","title":"凯赛生物：2023年前三季度净利润约3.14亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2379307906","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2379307906?lang=zh_cn&edition=full","pubTime":"2023-10-30 18:57","pubTimestamp":1698663430,"startTime":"0","endTime":"0","summary":"凯赛生物（SH 688065，收盘价：53.78元）10月30日晚间发布三季度业绩公告称，2023年前三季度营收约15.65亿元，同比减少14.81%；归属于上市公司股东的净利润约3.14亿元，同比减少35.44%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的董事长、总裁均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。截至发稿，凯赛生物市值为314亿元。文章来源：每日经济新闻原标题：凯赛生物：2023年前三季度净利润约3.14亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103019100783d2dce7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023103019100783d2dce7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","CBIO","GYRE"],"gpt_icon":0},{"id":"2378870508","title":"Catalyst Biosciences Inc盘中异动 早盘急速拉升6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2378870508","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2378870508?lang=zh_cn&edition=full","pubTime":"2023-10-27 21:43","pubTimestamp":1698414201,"startTime":"0","endTime":"0","summary":"北京时间2023年10月27日21时43分，Catalyst Biosciences Inc股票出现异动，股价大幅拉升6.66%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.74%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。消息层面，截至21时43分，《年报季·龙头系列 | 凯赛生物：业绩以及经营效率下滑，估值较低》资讯为影响Catalyst Biosciences Inc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102721432383978a74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102721432383978a74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO","GYRE"],"gpt_icon":0},{"id":"2378852295","title":"Catalyst Biosciences Inc盘中异动 大幅拉升7.55%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2378852295","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2378852295?lang=zh_cn&edition=full","pubTime":"2023-10-26 21:35","pubTimestamp":1698327329,"startTime":"0","endTime":"0","summary":"北京时间2023年10月26日21时35分，Catalyst Biosciences Inc股票出现波动，股价快速上涨7.55%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.41%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。消息层面，截至21时35分，《年报季·龙头系列 | 凯赛生物：业绩以及经营效率下滑，估值较低》资讯为影响Catalyst Biosciences Inc的重要信息。凯赛生物2023半年报A股排名1653，较上季度排名提高，较去年同期排名大幅下滑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102621353082ff2eda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102621353082ff2eda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO","GYRE"],"gpt_icon":0},{"id":"2378041090","title":"Catalyst Biosciences Inc盘中异动 早盘大幅拉升6.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2378041090","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2378041090?lang=zh_cn&edition=full","pubTime":"2023-10-25 21:46","pubTimestamp":1698241612,"startTime":"0","endTime":"0","summary":"北京时间2023年10月25日21时46分，Catalyst Biosciences Inc股票出现异动，股价快速上涨6.68%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.99%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。消息层面，截至21时46分，《年报季·龙头系列 | 凯赛生物：业绩以及经营效率下滑，估值较低》资讯为影响Catalyst Biosciences Inc的重要信息。凯赛生物2023半年报A股排名1653，较上季度排名提高，较去年同期排名大幅下滑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310252146538396bdb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310252146538396bdb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139","GYRE"],"gpt_icon":0},{"id":"2378029061","title":"年报季·龙头系列 | 凯赛生物：业绩以及经营效率下滑，估值较低（2023半年报）","url":"https://stock-news.laohu8.com/highlight/detail?id=2378029061","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2378029061?lang=zh_cn&edition=full","pubTime":"2023-10-25 10:58","pubTimestamp":1698202722,"startTime":"0","endTime":"0","summary":"凯赛生物2023半年报行业排名107，较上季度排名提高，较去年同期排名下滑。四核心财务特征2023半年报凯赛生物净利润2.64亿元，与2022半年报相比，净利润快速下滑。2023半年报凯赛生物经营资产报酬率0.68%。凯赛生物2023半年报经营活动现金净流入3.24亿元，较2023半年报减少0.37亿元，2021年报到本期经营活动累计产生净流入17.22亿元。2023半年报凯赛生物经营活动与投资活动资金缺口5.45亿元较2022半年报减少12.62亿元，缺口迅速缩小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310251110268221ab37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310251110268221ab37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK0208","688065","GYRE"],"gpt_icon":0},{"id":"2377508285","title":"Catalyst Biosciences Inc股价重挫10.84% 市值跌74.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2377508285","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2377508285?lang=zh_cn&edition=full","pubTime":"2023-10-24 21:35","pubTimestamp":1698154556,"startTime":"0","endTime":"0","summary":"北京时间2023年10月24日21时35分，Catalyst Biosciences Inc股票出现异动，股价急速下跌10.84%。截至发稿，该股报0.416美元/股，成交量6.7714万股，换手率0.18%，振幅9.33%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，联拓生物、Immunitybio Inc、Maia Biotechnology Inc涨幅较大，Transcode Therapeutics Inc、Maia Biotechnology Inc、联拓生物较为活跃，换手率分别为55.27%、18.59%、12.25%，振幅较大的相关个股有Immunitybio Inc、Eiger Biopharmaceuticals Inc、联拓生物，振幅分别为17.53%、15.90%、15.76%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102421355683965f51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102421355683965f51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139","GYRE"],"gpt_icon":0},{"id":"2377716410","title":"Catalyst Biosciences Inc盘中异动 快速跳水6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2377716410","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2377716410?lang=zh_cn&edition=full","pubTime":"2023-10-23 21:32","pubTimestamp":1698067945,"startTime":"0","endTime":"0","summary":"北京时间2023年10月23日21时32分，Catalyst Biosciences Inc股票出现波动，股价快速下跌6.94%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体涨幅为0.19%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。消息层面，截至21时32分，《康蒂尼药业与CATALYST BIOSCIENCES,INC.合并赴美IPO获中国证监会备案 拟在纳斯达克上市》资讯为影响Catalyst Biosciences Inc的重要信息。同时，公司完成境外发行上市后15个工作日内，应通过中国证监会备案管理信息系统报告发行上市情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231023213227821ca7e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231023213227821ca7e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139"],"gpt_icon":0},{"id":"2376249839","title":"Catalyst Biosciences Inc股价上涨17.03% 市值涨303.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2376249839","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2376249839?lang=zh_cn&edition=full","pubTime":"2023-10-20 21:31","pubTimestamp":1697808689,"startTime":"0","endTime":"0","summary":"北京时间2023年10月20日21时31分，Catalyst Biosciences Inc股票出现波动，股价急速拉升17.03%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.01%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。消息层面，截至21时31分，《康蒂尼药业与CATALYST BIOSCIENCES,INC.合并赴美IPO获中国证监会备案 拟在纳斯达克上市》资讯为影响Catalyst Biosciences Inc的重要信息。同时，公司完成境外发行上市后15个工作日内，应通过中国证监会备案管理信息系统报告发行上市情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102021313082152b37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102021313082152b37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"2376192245","title":"康蒂尼药业与CATALYST BIOSCIENCES,INC.合并赴美IPO获中国证监会备案 拟在纳斯达克上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2376192245","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2376192245?lang=zh_cn&edition=full","pubTime":"2023-10-20 20:49","pubTimestamp":1697806199,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月20日，证监会国际合作部发布关于北京康蒂尼药业股份有限公司境外发行上市备案通知书，康蒂尼药业此次通过与CATALYST BIOSCIENCES,INC.合并实现在美国纳斯达克证券交易所上市，CATALYST BIOSCIENCES,INC.同步发行不超过1110776224股普通股。同时，公司完成境外发行上市后15个工作日内，应通过中国证监会备案管理信息系统报告发行上市情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1009350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SQQQ","MNQmain","BK4139","CBIO","NQmain","QQQ","NDX","PSQ","BK4007","TQQQ","QLD","03086","QID",".IXIC","ARTL"],"gpt_icon":0},{"id":"2375160051","title":"未来产业 赢领明天丨凯赛生物：助力“碳中和”，引领可持续未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2375160051","media":"人民网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2375160051?lang=zh_cn&edition=full","pubTime":"2023-10-16 13:52","pubTimestamp":1697435540,"startTime":"0","endTime":"0","summary":"未来，凯赛生物还将进一步与客户、行业伙伴等各方深化合作，积极开拓产品下游潜在应用，共拓低碳产品，共塑可持续未来。2022年，凯赛生物持续推进连续纤维增强热塑性生物基聚酰胺复合材料的应用研发。对于未来，刘修才表示，凯赛生物将持续推动生物基产品及技术的迭代和创新，以己之力为中国乃至全球合成生物学及生物制造产业的发展提供正向驱动的力量，引领技术和行业共同可持续发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231016135931843ae22c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231016135931843ae22c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK0208","688065"],"gpt_icon":0},{"id":"2375945701","title":"Catalyst Biosciences Inc盘中异动 早盘股价大跌11.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2375945701","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2375945701?lang=zh_cn&edition=full","pubTime":"2023-10-13 21:31","pubTimestamp":1697203887,"startTime":"0","endTime":"0","summary":"北京时间2023年10月13日21时31分，Catalyst Biosciences Inc股票出现波动，股价急速下跌11.71%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Bio-Path Holdings Inc、Frequency Therapeutics Inc、Outlook Therapeutics Inc涨幅较大，Bio-Path Holdings Inc、Tempest Therapeutics Inc、Tracon Pharmaceuticals Inc较为活跃，换手率分别为258.17%、44.41%、33.09%，振幅较大的相关个股有Bio-Path Holdings Inc、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Bellerophon Therapeutics Inc，振幅分别为22.35%、18.97%、16.07%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101321312781ff6850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101321312781ff6850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139"],"gpt_icon":0},{"id":"2375966040","title":"北向资金10月12日净买入凯赛生物4.12万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2375966040","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2375966040?lang=zh_cn&edition=full","pubTime":"2023-10-13 09:30","pubTimestamp":1697160622,"startTime":"0","endTime":"0","summary":"10月12日, 北向资金增持凯赛生物4.12万股，连续3日增持。截止当日收盘，沪股通共持有凯赛生物219.07万股，占流通股0.54%。沪股通增持金额前五个股分别为招商银行、贵州茅台、药明康德、华友钴业、建设银行。凯赛生物近5个交易日下跌0.60%，沪股通累计增持24.43万股；近20个交易日下跌5.51%，沪股通累计增持123.76万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101309340281fd3f0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101309340281fd3f0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO","688065"],"gpt_icon":0},{"id":"2375930455","title":"Catalyst Biosciences Inc盘中异动 下午盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2375930455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2375930455?lang=zh_cn&edition=full","pubTime":"2023-10-13 01:19","pubTimestamp":1697131186,"startTime":"0","endTime":"0","summary":"北京时间2023年10月13日01时19分，Catalyst Biosciences Inc股票出现异动，股价大幅跳水5.18%。截至发稿，该股报0.405美元/股，成交量11.393万股，换手率0.30%，振幅5.85%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Edesa Biotech Inc、Atreca Inc、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Jaguar Health Inc、Tempest Therapeutics Inc、Atreca Inc较为活跃，换手率分别为570.17%、282.16%、144.07%，振幅较大的相关个股有Edesa Biotech Inc、Atreca Inc、Acurx Pharmaceuticals Inc，振幅分别为197.52%、129.70%、127.80%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101301194682fade87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101301194682fade87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"2374768115","title":"北向资金10月9日净卖出凯赛生物1.62万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2374768115","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2374768115?lang=zh_cn&edition=full","pubTime":"2023-10-10 09:30","pubTimestamp":1696901428,"startTime":"0","endTime":"0","summary":"10月9日，北向资金减持凯赛生物1.62万股连续5日减持。截止当日收盘，沪股通共持有凯赛生物189.82万股，占流通股0.47%。沪股通减持金额前五个股分别为隆基绿能、中国平安、中国中免、长江电力、紫金矿业。凯赛生物近5个交易日上涨0.82%，沪股通累计减持15.74万股；近20个交易日下跌6.22%，沪股通累计增持103.78万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101009335684272f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023101009335684272f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139","688065"],"gpt_icon":0},{"id":"2374516806","title":"凯赛生物：累计回购约46万股，占比0.078%","url":"https://stock-news.laohu8.com/highlight/detail?id=2374516806","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2374516806?lang=zh_cn&edition=full","pubTime":"2023-10-09 17:22","pubTimestamp":1696843320,"startTime":"0","endTime":"0","summary":"凯赛生物（SH 688065，收盘价：55.46元）10月9日晚间发布公告称，截至2023年9月30日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份约46万股，占公司总股本约5.83亿股的比例为0.078%。2022年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比95.55%。凯赛生物的总裁、董事长均是XIUCAI LIU(刘修才)，男，66岁，学历背景为博士。截至发稿，凯赛生物市值为324亿元。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100917291981f108ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100917291981f108ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065","CBIO"],"gpt_icon":0},{"id":"2372819348","title":"Catalyst Biosciences Inc盘中异动 股价大跌5.12%报0.465美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2372819348","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2372819348?lang=zh_cn&edition=full","pubTime":"2023-10-04 00:17","pubTimestamp":1696349853,"startTime":"0","endTime":"0","summary":"北京时间2023年10月04日00时17分，Catalyst Biosciences Inc股票出现波动，股价急速下挫5.12%。截至发稿，该股报0.465美元/股，成交量5.1204万股，换手率0.13%，振幅4.06%。Catalyst Biosciences Inc股票所在的生物技术行业中，整体跌幅为2.27%。Catalyst Biosciences Inc公司简介：凯赛生物公司是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100400173383906c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023100400173383906c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.catalystbiosciences.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Catalyst Biosciences, Inc.成立于1997年3月7日，位于特拉华州。该公司及其子公司是一家生物制药公司，专注于开发和商业化治疗NASH（非酒精性脂肪性肝炎，一种严重的非酒精性脂肪性肝病）在美国。目前正在对羟丙尼酮用于治疗与多种慢性肝病相关的肝纤维化进行评估。海度尼酮的1期临床试验已在美国完成，并在美国健康受试者中产生了单次和多次递增剂量海度尼酮的药动学、安全性和耐受性数据。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.040006},{"month":2,"riseRate":0.375,"avgChangeRate":-0.03658},{"month":3,"riseRate":0.375,"avgChangeRate":-0.061565},{"month":4,"riseRate":0.5,"avgChangeRate":-0.035187},{"month":5,"riseRate":0.5,"avgChangeRate":0.176759},{"month":6,"riseRate":0.375,"avgChangeRate":0.03031},{"month":7,"riseRate":0.25,"avgChangeRate":-0.037766},{"month":8,"riseRate":0.625,"avgChangeRate":0.031389},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.16575},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.051346},{"month":11,"riseRate":0.625,"avgChangeRate":-0.011059},{"month":12,"riseRate":0.5,"avgChangeRate":0.078007}],"exchange":"NASDAQ","name":"Catalyst Biosciences","nameEN":"Catalyst Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Catalyst Biosciences(CBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Catalyst Biosciences(CBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Catalyst Biosciences,CBIO,Catalyst Biosciences股票,Catalyst Biosciences股票老虎,Catalyst Biosciences股票老虎国际,Catalyst Biosciences行情,Catalyst Biosciences股票行情,Catalyst Biosciences股价,Catalyst Biosciences股市,Catalyst Biosciences股票价格,Catalyst Biosciences股票交易,Catalyst Biosciences股票购买,Catalyst Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Catalyst Biosciences(CBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Catalyst Biosciences(CBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}